Abstract
Fusion between androgen-regulated TMPRSS2 and ETS transcription factor gene ERG is the most frequent genetic alteration that occurs in 40–70% of prostate cancers. Not only ERG but also other ETS transcription factor genes are involved in gene fusions. ETV1, ETV4, and ETV5 have all several fusion partners. One common feature shared by the majority of these partners is androgen-regulated expression. Despite its high frequency, the biological and molecular effects of ETS gene fusion in prostate cancer development and progression are unknown. In this chapter quantitative polymerase chain reaction (Q-PCR) is used for detection and further studying the incidence and properties of these fusion transcripts. The focus is on the expression of TMPRSS2–ERG transcripts in clinical prostate samples. Androgen regulation of TMPRSS2 is measured in commonly used LNCaP prostate cancer cells grown with and without the synthetic androgen R1881. Furthermore, combining Q-PCR with 5′ RLM-RACE and sequencing are described for the identification of novel ETS fusion partners.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Tomlins SA, Rhodes DR, Perner S, et al. (2005) Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310:644–8.
Hermans KG, van Marion R, van Dekken H, Jenster G, van Weerden WM, Trapman J. (2006) TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancer. Cancer Res 66:10658–63.
Perner S, Demichelis F, Beroukhim R, et al. (2006) TMPRSS2-ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res 66:8337–41.
Wang J, Cai Y, Ren C, Ittmann M. (2006) Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer. Cancer Res 66:8347–51.
Pflueger D, Rickman DS, Sboner A, et al. (2009) N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer. Neoplasia 11:804–11.
Han B, Mehra R, Dhanasekaran SM, et al. (2008) A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer. Cancer Res 68:7629–37.
Tomlins SA, Mehra R, Rhodes DR, et al. (2006) TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer. Cancer Res 66:3396–400.
Helgeson BE, Tomlins SA, Shah N, et al. (2008) Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer. Cancer Res 68:73–80.
Tomlins SA, Laxman B, Dhanasekaran SM, et al. (2007) Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer. Nature 448: 595–9.
Seth A, Watson DK. (2005) ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 41:2462–78.
Turner DP, Watson DK. (2008) ETS transcription factors: oncogenes and tumor suppressor genes as therapeutic targets for prostate cancer. Expert Rev Anticancer Ther 8:33–42.
Lapointe J, Kim YH, Miller MA, et al. (2007) A variant TMPRSS2 isoformand ERG fusion product in prostate cancer with implication for molecular diagnosis. Mod Pathol 20: 497–73.
Saramaki OR, Harjula AE, Martikainen PM, et al. (2008) TMPRSS2:ERG fusion identifies a subgroup of prostate cancers with a favourable prognosis. Clin Cancer Res 14:3395–400.
Demichelis F, Fall K, Perner S, et al. (2007) TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort. Oncogene 26:4596–9.
Maher CA, Palanisamy N, Brenner JC, et al. (2009) Chimeric transcript discovery by paired-end transcriptome sequencing. Proc Natl Acad Sci USA 106: 12353–8.
Jhavar S, Reid A, Clark J, et al. (2008) Detection of TMPRSS2-ERG translocations in human prostate cancer by expression profiling using GeneChip human exon 1.0 ST Arrays. J Mol Diagn 10:50–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Gasi, D., Trapman, J. (2011). Androgen Regulation of ETS Gene Fusion Transcripts in Prostate Cancer. In: Saatcioglu, F. (eds) Androgen Action. Methods in Molecular Biology, vol 776. Humana Press. https://doi.org/10.1007/978-1-61779-243-4_19
Download citation
DOI: https://doi.org/10.1007/978-1-61779-243-4_19
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-242-7
Online ISBN: 978-1-61779-243-4
eBook Packages: Springer Protocols